Learn how to build decision-grade disease registries that turn real-world data into reliable evidence for regulatory, clinical, and market-access decisions.
- Inside A Sponsor-Site Relationship That Actually Worked
- Real-World Data Won't Replace Trials. Here's Its Real Job
- Inside Virtua Health's Pipeline For Anonymizing Trial Imaging Data
- What Ecological Momentary Assessment Taught Us About Real-World Hearing Outcomes
- AI Governance Is Becoming A Competitive Edge In Trials
- Why The Biostatistician's Seat At The Table Keeps Vanishing
- Is Moving From One-Off Solutions To A Technology Platform The Best Fit For Your R&D?
- From 73% Noncompliant To 2.4%: Building A Compliance Office
ON-DEMAND WEBINARS
Dr. Jie Shen, Research Fellow and Director of Digital Science at AbbVie, shares lessons learned from incorporating digital measures of physical activity into Phase 3 immunology clinical trials.
In an era defined by rapid disruption and technological advancement, clinical operations leaders are under increasing pressure to enhance effectiveness while managing complex strategic trade-offs.
This webinar explores the ways in which RTSM systems can enable speed, agility, and flexibility in infectious disease studies.
The benefits of integrating EHR data with an EDC range from reducing duplicate documentation and errors to enriching the clinical dataset with real-world data. Why aren’t more people doing it?
ARTICLES, APP NOTES, CASE STUDIES, & WHITE PAPERS
-
![Mobile Device Management]( "Beyond The Pandemic: Why eCOAs Are Here To Stay")
Beyond The Pandemic: Why eCOAs Are Here To StayThe permanent adoption of eCOA is a natural step in the industry-wide effort to create a more patient-centric clinical trial experience. Learn more in the available blog.
-
![GettyImages-1435078862 esource]( "Drive Superior Enrollment, Speed, And Quality Using eSource")
Drive Superior Enrollment, Speed, And Quality Using eSourceExplore a detailed analysis of 140 research sites involved in a Phase III trial, highlighting significant advancements in trial performance and data quality using CRIO’s eSource platform.
-
![Data-security-privacy-GettyImages-1162361864]( "Beginner's Guide To 21 CFR Part 11 Compliance")
Beginner's Guide To 21 CFR Part 11 ComplianceComputer systems used for clinical trials fall under Food and Drug Administration (FDA) 21 CFR Part 11. While Part 11 is widely known, this blog explains how it fits in with your research software.
-
![Big data-GettyImages-1023943076]( "eSource vs. EDC: Reimagining Your Clinical Trials")
eSource vs. EDC: Reimagining Your Clinical TrialsExplore how an eSource approach to clinical trial data can reduce site burden, eliminate double data entry, minimize queries, and enhance remote monitoring.
-
![GettyImages-1300754555-connectivity-communication-network]( "Enhancing Information Dissemination")
Enhancing Information DisseminationBy utilizing advanced digital solutions, Medical Affairs (MA) teams can optimize workflows, reduce their operational burdens, and elevate the quality of communication.
-
![Smart businessman looking forward in spyglass -iStock-1085606706]( "The Power Of Predictive Analytics In Clinical Trial Design")
The Power Of Predictive Analytics In Clinical Trial DesignDiscover how predictive analytics address clinical trial challenges by applying statistical and modeling techniques to current and historical data.
-
![Getty Images_ 2156307947_medical-trial-coding-clinical]( "A New Take On The Evolving Role Of AI In Clinical Trials")
A New Take On The Evolving Role Of AI In Clinical TrialsArtificial intelligence is shifting from promise to practice in biopharma. Zhong Lu, director of data science and AI at Novartis, outlines how AI is evolving the clinical trials process end-to-end.
-
![GettyImages-639015264 patient, smartphone]( "Overcoming Participant Compliance Challenges In A Medical Device Study")
Overcoming Participant Compliance Challenges In A Medical Device StudyUncover how Catalyst Clinical Research enhanced participant compliance and streamlined scheduling for a TENS device study using the TrialKit platform, with crucial support from CDS.
-
![GettyImages-1357084676 wearables]( "5 Important Questions To Ask Your Wearable Technology Partner")
5 Important Questions To Ask Your Wearable Technology PartnerDiscuss these questions with any wearable technology partner to establish a solid foundation for a successful collaboration that maximizes the potential of wearable DHTs in your clinical research endeavors.
-
![Digital technology-GettyImages-826921436]( "Accelerating Site Activation: Examples From Novartis And IQVIA")
Accelerating Site Activation: Examples From Novartis And IQVIAAs protocols and studies become more complex, using technology to offer sites in-depth expertise and guidance is more important than ever to launch studies on time.
RECENT NEWSLETTERS
- 10.08.26 -- AI, RTSM, And Trial Systems Are Still Breaking Down
- 10.03.26 -- Best Of September: AI, Wearables, And Trial Workflow Gaps
- 10.01.26 -- AI, Data Integrity, And Wireless Gaps Are Reshaping Trials
- 09.24.26 -- AI, Wearables, And CRA Workflows Are Exposing Trial Gaps
- 09.17.26 -- AI, Wearables, And eTMF Are Exposing Trial Data Gaps
